Firm Vice Chair, Panelist at ACI's 23rd Annual Drug & Medical Device Conference
Bowman and Brooke sponsored and Kim Schmid, Firm Vice Chair and Executive Managing Partner, spoke at the 23rd Annual ACI Drug and Medical Device Litigation Conference in New York City, November 28-30, 2018. Kim joined a panel presenting, Practical Ways for Incorporating Diversity and Inclusion into Your Trial Team and Litigation Strategy. Kim’s co-panelists were Sonia Chen Arnold, Assistant General Counsel – Litigation and Legal Compliance, Eli Lilly and Company, Rachel Gallagher, Director, Legal Counsel, Teva Pharmaceuticals USA, Inc. and Robert R. Simpson, Partner, Shipman & Goodwin LLP.
Widely regarded as the go-to annual conference for the pharmaceutical and medical device products liability community, this event showcases a prominent faculty of 20+ in-house counsel, 10+ judges and government officials and 20+ leading law firms addressing the most pressing issues affecting the pharmaceutical and medical device industries today and where they see these industries heading.